Neogen Profits Fall On Integration Of Acquisitions; Revenue RisesThe Lansing animal and food safety testing product maker Neogen Corp. (Nasdaq: NEOG) Tuesday announced net income of $6.6 million for for the third quarter of its fiscal year, which ended Feb. 28, down from $6.7 million in the same period a year earlier. Earnings per share was unchanged at 18 cents for both periods. Revenue for the quarter was $62 million, up 21 percent from $51.1 million a year earlier.
Lansing's Neogen Buys Iowa Insecticide MakerA 35-year-old Iowa company that makes environmentally friendly insecticides for the animal and food industries has been acquired by Lansing's Neogen Corp.
Neogen Profit Falls On Fewer Food Contamination Crises, Higher Acquisition CostsNeogen Corp. makes products that test for contamination and other biotech information in food and livestock. A year ago, amid outbreaks of food contamination, the company reported record profits. This year, for the second quarter of its fiscal year, which ended Nov. 30, the company reported lower net income despite higher sales due to what a top executive called a year of "clean crops." Acquisition expenses also played a part.
Neogen Announces 3-for-2 Stock SplitNeogen Corp. (Nasdaq: NEOG) announced that its Board of Directors has approved a three-for-two stock split. With the split, shareholders of record on Oct. 15 will receive one additional share of stock for each two shares held.
Neogen Buys Iowa Vet Business SyrVet Inc.Neogen Corp. (Nasdaq: NEOG) Monday announced that it has acquired the assets of SyrVet Inc., a veterinary instrument business based in Waukee, Iowa. Price and other terms weren't immediately disclosed.
Neogen Launches Comprehensive Dairy Heifer Genomic TestThe biotech developer Neogen Corp. (Nasdaq: NEOG) Thursday announced the development of a new genomic test that offers the dairy cattle industry an unprecedented level of information on the genetic potential of replacement dairy heifers.
HR Notices From June 10The latest staffing, leadership and boardroom news from Michigan's technology focused companies, groups and institutions
Neogen Launches Comprehensive Cattle Genomic TestNeogen Corp. (Nasdaq: NEOG) Monday announced the development of a new genomic test that offers the beef cattle industry an unprecedented level of information on the genetic potential of individual animals.
Neogen Sales Spike Over Concerns Of Horse Meat In BeefNeogen Corp. announced Tuesday that it has seen a spike in sales of its rapid meat speciation test kits as beef processors scramble to respond to the unscrupulous use of horse meat, and other species of meat, in the "economic adulteration" of beef products.
Neogen Acquires Scidera GenomicsNeogen Corp. (Nasdaq: NEOG) announced today that it has acquired the assets of Scidera Genomics LLC, an animal genomics business based in Davis, Calif. The company, formerly operated as MetaMorphix Inc., or MMI Genomics, was a pioneer in the development of cattle, poultry, swine, and canine genetic testing.
Neogen Acquires Macleod PharmaceuticalsNeogen Corp. announced that it has acquired the stock of Macleod Pharmaceuticals, an animal health company headquartered in Fort Collins, Colo. The family-owned business is the original manufacturer of Uniprim, a popular antibiotic for horses.
Neogen Reports Reports Record First Quarter Revenue, Net IncomeNeogen Corp. announced net income of $6.7 million or 28 cents a share in the first fiscal quarter, which ended Aug. 31, up 11.8 percent from $6 million or 25 cents a share in the same quarter of the prior fiscal year.
Neogen Launches Ansr For ListeriaThe Lansing-based biotech company Neogen Corp. said Monday it had developed the quickest and easiest test to definitively detect for contamination with Listeria bacteria.
Neogen Acquires Igenity From MerialNeogen Corp. (Nasdaq: NEOG) announced Tuesday that it has acquired the assets of the Igenity animal genomics business from Merial Limited.
Neogen Reports Third Quarter Revenue, Net Income RiseThe Lansing biotech products developer reported a healthy increase in both sales and profitability in the fiscal quarter ended Feb. 29.